$47.01
0.16% day before yesterday
NYSE, Dec 05, 10:00 pm CET

QIAGEN NV Stock price

$47.01
+2.96 6.72% 1M
+1.45 3.18% 6M
+1.21 2.64% YTD
+2.34 5.24% 1Y
-5.14 9.86% 3Y
-4.90 9.43% 5Y
+17.65 60.13% 10Y
+34.43 273.83% 20Y
NYSE, Closing price Fri, Dec 05 2025
-0.07 0.15%

New AI Insights on QIAGEN NV Insights AI Insights on QIAGEN NV

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$10.2b
Enterprise Value
$10.6b
Net debt
$437.2m
Cash
$1.7b
Shares outstanding
216.8m
Valuation (TTM | estimate)
P/E
25.5 | 19.4
P/S
4.9 | 4.8
EV/Sales
5.1 | 5.0
EV/FCF
22.5
P/B
2.8
Dividends
DPS
$1.55
Yield 1Y | 5Y
3.3% | 1.2%
Growth 1Y | 5Y
13.9% | -
Payout 1Y | 3Y
357.2% | 35.6%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$2.1b | $2.1b
EBITDA
$567.1m | $787.8m
EBIT
$559.5m | $604.3m
Net Income
$405.4m | $526.4m
Free Cash Flow
$472.5m
Growth (TTM | estimate)
Revenue
5.3% | 7.4%
EBITDA
17.5% | 56.1%
EBIT
18.6% | 22.1%
Net Income
336.2% | 529.7%
Free Cash Flow
2.8%
Margin (TTM | estimate)
Gross
64.1%
EBITDA
27.4% | 37.1%
EBIT
27.0%
Net
19.6% | 24.8%
Free Cash Flow
22.8%
Financial Health
Equity Ratio
62.7%
Return on Equity
2.3%
ROCE
10.0%
ROIC
9.5%
Debt/Equity
0.6
More
EPS
$1.8
FCF per Share
$2.2
Short interest
4.2%
Employees
5k
Rev per Employee
$380.0k
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a QIAGEN NV forecast:

12x Buy
50%
12x Hold
50%

Analyst Opinions

24 Analysts have issued a QIAGEN NV forecast:

Buy
50%
Hold
50%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,071 2,071
5% 5%
100%
- Direct Costs 743 743
3% 3%
36%
1,327 1,327
7% 7%
64%
- Selling and Administrative Expenses 572 572
1% 1%
28%
- Research and Development Expense 189 189
1% 1%
9%
567 567
18% 18%
27%
- Depreciation and Amortization 7.53 7.53
28% 28%
0%
EBIT (Operating Income) EBIT 560 560
19% 19%
27%
Net Profit 405 405
336% 336%
20%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
Seeking Alpha
4 days ago
Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Neutral
Seeking Alpha
5 days ago
Qiagen N.V. (QGEN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Neutral
Seeking Alpha
16 days ago
Qiagen N.V. ( QGEN ) Deep Dive Into Sample Technologies: Leadership, Innovation and Future Expansion November 21, 2025 9:00 AM EST Company Participants Domenica Martorana - Associate Director of Global Investor Relations Thierry Bernard - CEO, MD & Member of Management Board Daniel Wendorff John Gilardi - VP & Head of Corporate Communications Michael Scheffler Nitin Sood - Senior VP & Head of P...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,232
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today